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Abstract
Background: Although chronic cough is a common problem in clinical practice, data on the
prevalence and characteristics of cough in the general population are scarce. Our aim was to
determine the prevalence of chronic cough that is not associated with diagnosed respiratory
conditions and examine the impact on health status and psychological health, in a representative
adult population cohort
Methods: North West Adelaide Health Study (n stage 1 = 4060, stage 2 = 3160) is a representative
population adult cohort. Clinical assessment included spirometry, anthropometry and skin tests.
Questionnaires assessed demographics, lifestyle risk factors, quality of life, mental health and
respiratory symptoms, doctor diagnosed conditions and medication use.
Results: Of the 3355 people without identified lung disease at baseline, 18.2% reported chronic
cough. In multiple logistic regression models, at follow-up, dry chronic cough without sputum
production was significantly more common in males (OR 1.5, 95% CI 1.1, 1.9), current smokers
(OR 4.9, 95% CI 3.4, 7.2), obesity (OR 1.9, 95% CI 1.3, 2.9), use of ACE inhibitors (OR 1.8, 95% CI
1.1, 2.9), severe mental health disturbance (OR 2.1, 95% CI 1.4, 3.1) and older age (40-59 years OR
1.7 95% CI 1.2, 2.4; ≥ 60 years OR 2.1 95% CI 1.3, 3.5). Among non-smokers only, all cough was
significantly more common in men, those with severe mental health disturbance and obesity.
Conclusions: Chronic cough is a major cause of morbidity. Attention to cough is indicated in
patients with obesity, psychological symptoms or smokers. Inquiring about cough in those with
mental health problems may identify reversible morbidity.
Background
Cough is the commonest symptom seen in primary care
[1-3], and chronic cough is one of the most frequent rea-
sons for new referrals to specialist pulmonologists [4].
However, data on the prevalence of cough lasting more
than eight weeks in the general population are scarce
[5,6]. Most reports of the prevalence of chronic cough in
adults originate from specialist cough clinics and there-
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fore reflect the experience of chronic cough in secondary
or tertiary care. The prevalence of chronic cough (lasting
more than eight weeks) has been variously reported at
10% to 30% [5,7,8]. Where population data exist they are
limited by methodological problems, including use of
selected age groups [9-13], self selection of questionnaire
respondents [6], failure to differentiate between acute
cough due to infection and chronic cough [14]; or a lack
of information on other respiratory conditions [10] mak-
ing it difficult to differentiate the impact of chronic cough
from that of airways diseases such as asthma.
Chronic cough is associated with adverse effects on
health-related quality of life [15-17]. Successful treatment
of cough often leads to major improvement in quality of
life [15,16]. Chronic cough is also associated with psycho-
social problems that may be more pronounced than phys-
ical effects [6,15,16,18]. However, the few studies that
have evaluated the impact of cough on health status or
psychological health have sampled from specialist clinic
populations [19,20] rather than the general population.
Others studies are limited by the lack of use of a validated
instrument of psychological health [6].
Our aim was to determine the prevalence of chronic
cough in a representative adult population cohort, partic-
ularly cough that is not associated with diagnosed respira-
tory conditions, and examine the impact on health status
and psychological health.
Methods
Sample population and study method
The North West Adelaide Health Study (NWAHS) is a rep-
resentative biomedical longitudinal population cohort
study of people aged eighteen years or older, randomly
selected from the electronic white pages telephone direc-
tory and living in the north western suburbs of Adelaide,
South Australia (regional population 0.6 million).
NWAHS initially recruited between 2000 and 2002 with
follow-up in 2004-05. The methods of the North West
Adelaide Health Study [21] and the validity of these meth-
ods of selection to achieve an unbiased sample have been
described previously [22]. In particular, there were no
major differences between study participants and the
comparison population in terms of health indicators or
lifestyle behaviours [23].
At stage 1, 4060 adults underwent biomedical examina-
tion, representing 69% of those who completed the tele-
phone interview. Overall, at Stage 2 follow-up (mean
follow-up time = 3.5 years, range 1.7-5.8 years) survey
data was obtained on 88% (n = 3574) and clinic data on
79% (n = 3206) of the Stage 1 NWAHS population using
the same methodology and questions. One hundred sub-
jects were deceased, 226 persons were unable to be con-
tacted, and 160 refused further participation in the study.
Telephone interviews investigated self-reported health sta-
tus (including asthma and COPD), smoking status and
demographic variables. A self-completed questionnaire
comprised items on demographic information, risk fac-
tors (smoking, alcohol use), quality of life, mental health
and respiratory symptoms. Smoking was categorized into
self-reported current, former or never smoker. Clinic
assessment by trained technicians included spirometry
according to American Thoracic Society criteria [24], skin
prick testing to a panel of eight common allergens, and
measurement of height, weight. Obesity was classified as
follows: Body mass index [25] (BMI) in kilograms/metre2:
Underweight: ≤ 18.49; Normal: 18.5-24.9; Overweight:
25.0-29.9; Obesity: ≥ 30.0. Medication use was identified
when participants were also asked to bring all current
medicines (including complementary medicines) into the
clinic at their appointment.
Respiratory measures
Asthma was defined as current self-reported physician-
diagnosed asthma or demonstration of a significant bron-
chodilator response (SBR) of at least 12% of baseline FEV1
in the absence of a doctor diagnosis of asthma [26,27].
Participants with persistent airways obstruction (post-
bronchodilator FEV1/FVC ratio less than 0.70) [28] were
identified. Respiratory symptoms were assessed with the
validated Chronic Lung Disease (CLD) Index [29,30]. This
is a 6-item instrument that includes items relating to fre-
quency and intensity of dyspnea and wheeze and fre-
quency of coughing and volume of sputum production.
Chronic cough was defined as cough reported on most/
every day in the past three months. Sputum was defined
as at least 2 or 3 tablespoons per day.
Quality of life and Psychological measures
Health-related quality of life was assessed using the Med-
ical Outcomes Study Short Form 36 Health Survey (SF-36)
Physical Health Component Summary (PCS) and Mental
Health Component Summary (MCS) scores [31]. The PCS
score is constructed such that the mean for the general
population is set at 50 with a standard deviation of 10,
and higher scores indicate better quality of life [32]. At
Stage 1 psychological health was measured by the General
Health Questionnaire (GHQ-28), a well-validated and
extensively used instrument designed to measure current
psychiatric and affective disorders with a focus on disrup-
tions to normal functioning rather than life-long traits
[33]. The GHQ-28 contains four subscales: anxiety and
insomnia, somatic symptoms (other than cough), social
dysfunction, and severe depression [34], providing more
information than that of a single severity score [34]. It
screens, therefore, for acute rather than chronic condi-Cough 2009, 5:10 http://www.coughjournal.com/content/5/1/10
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tions [35]. Scores can be interpreted as indicating the
severity of psychological disturbance on a continuum
[35]. In Australian community populations the GHQ-28
has shown sensitivity of 90% and specificity of 94% for
clinically confirmed diagnoses based on the Composite
International Diagnostic Interview [36]. At follow-up the
GHQ-12 was used, which excludes items most usually
selected by physically ill individuals. The GHQ-12 has
shown very similar figures to the GHQ-28 in validation
studies [35].
Statistical analysis
Data were weighted to the 1999 Estimated Residential
Population for South Australia [37] and Census data [38]
by region, age group, gender and probability of selection
in the household, to provide population representative
estimates. Data were analyzed using the Statistical Pack-
age for the Social Sciences (SPSS Version 15.0, SPSS Inc,
Chicago, IL). Multivariable logistic regression analyses
were conducted to assess the association of GHQ distur-
bance with chronic cough (all, dry, cough with sputum)
after adjustment for sex, age, smoking, BMI and ACE
inhibitor use. The models were also adjusted for reflux
medication use as a proxy for GERD. An additional model
assessing the association of all cough and GHQ distur-
bance was conducted in the population of never/former
smokers.
Approval for the NWAHS study was obtained from insti-
tutional ethics committees of the North West Adelaide
Health Service, and all subjects gave written informed
consent.
Results
The socio-demographic characteristics and health status
of the study subjects at Stage 1 baseline have been
described in detail previously [21,23]. Of the 3206 people
who attended for biomedical assessment at follow-up,
doctor-diagnosed current asthma was reported by 439
people (13.5%). Emphysema had been diagnosed in 43
(1.3%) and chronic bronchitis in 239 (7.3%). Airways
obstruction (post-bronchodilator FEV1/FVC <70%) was
found in 150 (4.8%), and significant acute FEV1 reversi-
bility (>12% & 0.2 L) in 128 (4.1%).
The prevalence of chronic cough at baseline within vari-
ous demographic and clinical groups is shown in Table 1.
Among people without identified airways or restrictive
respiratory disease, chronic cough with or without spu-
tum was more common in males, current smokers, those
aged less than 40 and over 55 years, and in those with
GHQ-28 identified psychological morbidity. Chronic
cough was more common across the GHQ-28 domains of
anxiety and insomnia, somatic symptoms, social dysfunc-
tion and severe depression. Table 2 shows the prevalence
of chronic cough by type, in relation to participant charac-
teristics at follow-up. Among people without identified
respiratory disease, chronic cough was more common in
males, current smokers, participants with high levels of
psychological disturbance, and fair to poor general health,
and in those using ACE inhibitors. Dry cough, which was
more prevalent in older participants, was more common
than cough productive of sputum across all population
categories, including smokers. The prevalence of cough
was not significantly different between former smokers
and those who had never smoked.
In multiple regression analysis (Table 3), chronic cough
without sputum production was seen more commonly in
males, current smoking and with ageing. There were sig-
nificant positive associations with severe depression,
obesity and use of ACE inhibitors. Modest, but marginally
non-significant associations were seen with atopy, and use
of anti-reflux treatment. Cough productive of sputum was
also more common in males and current smokers, and
less common in those who were overweight. Again, a sig-
nificant association was seen with severe depression.
Cough with sputum was not significantly associated with
use of ACE inhibitors or anti-reflux treatment. When the
analysis was confined to only non-smokers, all cough was
more common in men; those with severe depression, the
obese, and those aged over 60 years. Again, non-signifi-
cant associations were seen with atopy, and ACE-inhibitor
use (Table 3). When models were analyzed without the
GHQ variable, no changes were seen in the size of the
associations with other variables and cough.
Participants reporting cough at any time were significantly
more likely to have psychological disturbance on the
GHQ-12 and report significantly lower quality of life
compared to those without cough at any time (Table 4).
Compared to people with cough at both time points,
those with cough only at follow-up only had significantly
higher mean PCS scores and a lower prevalence of severe
psychological disturbance on the GHQ-12, although this
was not statistically significant. Compared to people with
cough at both time points, those with cough only at base-
line had higher mean levels of both PCS and MCS scores,
and a lower prevalence of any type of psychological dis-
turbance on the GHQ-12, although this was not statisti-
cally significant (p = 0.1).
Discussion
In a representative population sample we have shown that
chronic, dry cough is common among people without
known respiratory disease, with a prevalence of nearly 9%
among adults. Cough productive of sputum occurs in
around a further 4% of those without known lung disease.
People with chronic cough report significant impairments
in quality of life and psychological health, compared toCough 2009, 5:10 http://www.coughjournal.com/content/5/1/10
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those without cough. Across the population, chronic
cough was significantly associated with obesity and severe
depression, and was more common in men and in people
aged over 60 years. Although cough was more common in
people who currently smoke, when only non-smokers
were analyzed, the significant associations seen with
depression, obesity, men and age persisted. The preva-
lence of cough was not significantly different between
former smokers and those who had never smoked.
The frequency of chronic cough independent of other
lung disease, with its strong associations with impaired
mental health, particularly depression, and significantly
reduced quality of life, indicates cough is a major contrib-
utor to morbidity in the community. The reduction in
quality of life in general physical health is similar to that
previously reported in Australian populations for asthma
[39], diabetes [40], arthritis [41] and depression alone
[40]. Although use of a cough-specific quality of life
instrument may have elicited issues more closely related
to cough, the SF-36 correlates well with instruments such
as the Leicester Cough Questionnaire [17]. That major
impairments were seen in a general health instrument
indicates that chronic cough is not a minor problem and
deserves thorough evaluation and treatment, particularly
as most patients are able to respond to treatment for
chronic cough [42].
Our data demonstrates that careful attention should be
given to assessment and management of psychological
morbidity in the large number of patients with chronic
cough in the community, as well as those seen in referral
centers. This may be especially the case in people in whom
coughing persists in the absence of an identifiable cause
and despite extended trials of empirical therapy [43].
Chronic cough was common in smokers and smoking is
associated with depression and mental health problems
[44]. However, we found the association between chronic
cough and disturbance on the GHQ remained strong
when only non-smokers were included in the analysis.
Under-diagnosis of depression in patients with somatiza-
tion, particularly major depression, has recently been
Table 1: Prevalence (%) of all cough within baseline categories of demographic characteristics and mental health status in subjects 
without identifiable respiratory disease (n = 3355).
Cough +/- sputum
All subjects (n = 3960) 20.5
No respiratory disease (n = 3355) 18.2
Sex Male 18.5
Female 16.0
Smoking status Current 29.6
Former 15.6
Never 11.8
Age (years) < 40 20.0
40-54 12.2
55 and over 18.7
GHQ 28
Mental health condition Yes 26.9
No 14.2
Somatic symptoms Yes 27.6
No 14.0
Anxiety and insomnia Yes 23.6
No 15.4
Social dysfunction Yes 28.3
No 15.2
Severe depression Yes 34.4
No 15.7Cough 2009, 5:10 http://www.coughjournal.com/content/5/1/10
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identified as a significant problem in primary care [45].
Conversely, inquiry regarding cough in patients with
mental health problems may also be crucial in identifying
reversible morbidity in this group. In one study, successful
treatment of cough was correlated with improvements in
depression scores in 70% of patients [19].
We found obesity to be significantly associated with dry
cough and cough in never/ex-smokers. Janson et al have
reported cough was significantly associated with obesity.
However, the study population of 20-48 year olds
included people with asthma and other respiratory dis-
eases [9]. As obesity has been shown to be significantly
associated with asthma, it was unclear from that study
whether obesity was linked to chronic cough independ-
ently of airways diseases. One possibility is that obesity
increases the risk for gastro-esophageal reflux that is con-
tributing to chronic cough in people with obesity. Regard-
less, our study indicates that chronic cough, with the
concomitant problems of impairments in quality of life
and mental health, needs to be added to the burden and
morbidity of obesity in the community.
Comparison with previous studies examining the preva-
lence and associations of chronic cough are difficult due
to differences in sampling and other methodological
questions. We used a validated symptom score of chronic
lung disease to identify cough frequency over the previous
Table 2: Prevalence of dry and productive cough at follow-up in subjects with and without identifiable respiratory disease according to 
respiratory conditions, demographic characteristics, and health status.
Dry cough Cough + sputum
All subjects (n = 3206) 12.1 4.6
Respiratory disease
Asthma* (433) 25 6
Emphysema† (43) 37 23
Chronic bronchitis† (227) 22 12
Airways obstruction** (150) 30 11
≥ 12% FEV1 reversibility (129) 14 9
No respiratory disease (n = 2408) 8.8 3.8
Sex Male 10.3 4.9
Female 7.3 2.6
Smoking status Current 20.9 7.3
Former 6.6 2.4
Never 5.5 3.3
Age (years) < 40 6.3 4.9
40-54 10.5 3.6
55 and over 10.4 1.9
Atopy Yes 9.2 4.3
No 8.0 2.9
ACE inhibitor use Yes 14.4 2.7
No 8.3 3.8
GHQ disturbance High 15.9 7.8
Low/none 7.7 3.2
Self-rated health general health Fair/Poor 19.3 6.0
Good/excellent 8.8 2.2
SF - 36 Mean (SE) PCS 44.5 (0.5) 44.7 (0.8)
MCS 49.6 (0.6) 47.8 (1.0)
* asthma: self reported current doctor diagnosed.
† Self reported doctor diagnosed emphysema and chronic bronchitis,
** Airways obstruction = post-bronchodilator FEV1/FVC < 0.07Cough 2009, 5:10 http://www.coughjournal.com/content/5/1/10
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3 months. The use of this tool differs from prior studies
and makes direct comparison of prevalence between stud-
ies difficult. Studies using selected age groups have either
excluded adults aged > 50 [9] or > 60 years [11] in whom
chronic cough is common [11], thereby missing a large
proportion of people with chronic cough. Coultas et al
reported a prevalence of cough of 9.3% in people without
airflow obstruction from US population data but limited
the analysis to adults aged at least 45 years and did not
analyse any associations with obesity or psychological dis-
turbance [13]. Zemp et al reported the prevalence of
chronic bronchitis symptoms over ≥ 2 years in adults aged
less than 60 years [11]. Similar to our data they found no
difference in prevalence in cough with sputum between
never and former smokers (7%), with cough more com-
mon in current smokers (16.7%) [11]. Another commu-
Table 3: Multivariate logistic regression models for cough at follow-up in those without identifiable respiratory disease (n = 2408) and 
among never/ex-smokers (n = 1938).
All cough Dry cough Cough+sputum
All subjects Non-smokers
OR (95%C.I.) OR (95%C.I.) OR (95%C.I.) OR (95%C.I.)
Male 1.6 (1.3-2.1) 1.5 (1.05-2.0) 1.4 (1.02-1.9) 2.3 (1.4-3.6)
Age
18-39 1.0 1.0 1.0 1.0
40-59 1.5 (1.1-2.0) 1.4 (0.9-2.0) 1.9 (1.3-2.7) 0.7 (0.4-1.2)
60+ 1.7 (1.1-2.5) 1.8 (1.2-2.8) 2.6 (1.6-4.1 0.6 (0.3-1.3)
GHQ disturbance
mild-moderate 1.03 (0.7-1.6) 0.9 (0.5-1.6) 1.1 (0.7-1.8) 0.8 (0.4-1.8)
severe 2.2 (1.6-3.0) 1.8 (1.2-2.9) 2.1 (1.4-3.1) 2.6 (1.5-4.3)
Smoking status
former smoker 0.9 (0.7-1.3) - 1.01 (0.7-1.5) 0.8 (0.4-1.4)
current 4.1 (3.0-5.5) - 5.4 (3.8-7.8) 2.5 (1.5-4.0)
ACE inhibitor use 1.6 (1.02-2.5) 1.4 (0.9-2.3) 1.8 (1.1-2.9) 1.1 (0.4-2.9)
Atopic 1.3 (0.97-1.7) 1.3 (0.9-1.8) 1.2 (0.9-1.7) 1.4 (0.9-2.2)
Anti-reflux agents 1.3 (0.8-2.0) 1.2 (0.7-2.0) 1.3 (0.8-2.0) 1.5 (0.7-3.4)
BMI
overweight 1.00 (0.7-1.4) 1.2 (0.8-1.8) 1.4 (0.96-2.1) 0.5 (0.3-0.8)
obese 1.5 (1.1-2.0) 1.7 (1.1-2.6) 2.0 (1.2-2.9) 0.9 (0.5-1.5)
Table 4: Prevalence of GHQ-12 disturbance and SF-36 PCS and MCS scores [mean (SE)] among those with and without cough at 
baseline and follow-up.
Cough % GHQ disturbance (n) SF-36 Mean (SE)
severe ≥ mild PCS MCS
Baseline Follow-up
No No 10.0 (182) 21.0 (381) 51.4 (0.2) 52.8 (0.2)
Yes 21.2* (33) 31.4* (49) 47.0* (0.7) 47.2* (0.7)
Yes No 16.9 (40) 30.9 (73) 47.4 (0.6) 49.0 (0.6)
Yes 24.8* (35) 36.2* (51) 44.6*†‡ (0.8) 46.3*‡ (0.8)
* p < .01 vs never cough
† p < .01 vs cough only at follow-up
‡ p < .01 vs cough only at baselineCough 2009, 5:10 http://www.coughjournal.com/content/5/1/10
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nity-based study sampled members of the public who
requested an information sheet following a national UK
radio broadcast, with risk of self-selection of question-
naire respondents [6]. Studies differentiating between
infection related acute cough and chronic cough were lim-
ited by a lack of information on other respiratory condi-
tions [10] or lung function [46] limiting the ability to
differentiate the impact of cough from that of airways dis-
eases such as asthma. Other population studies did not
differentiate acute from chronic cough [14]. The strength
of our study is that it comes from a representative popula-
tion sample that was able to identify people with cough
over a 3-month period, and those with airways obstruc-
tion or restriction on spirometry, previously diagnosed
respiratory disease, and current medication use, adding to
the generalizability of the findings.
Similar to other reports we found chronic cough is associ-
ated with adverse effects on health-related quality of life
[15-17] and psychological problems [6,15,16,18]. How-
ever, previous studies reporting increased levels of emo-
tional upset have been limited to small numbers of
patients referred to specialist cough clinics [19,20]. As
only a small part of the population identified in epidemi-
ological surveys seek medical help or advice for cough [5]
the population burden of disease from psychological
problems associated with cough cannot be extrapolated
from these studies. These studies in selected populations
have revealed increased levels of depression [19,20] and
anxiety using validated questionnaires [20] at frequencies
comparable or in excess of that seen in other serious
chronic diseases, such as diabetes, asthma or HIV-AIDS
[47-49]. Other reports linking cough to psychological
morbidity have either not used a validated instrument of
psychological health [6] or were unable to specify the fre-
quency, quality, duration, or intensity of reported cough-
ing making it difficult to identify the contribution of
chronic cough to this finding [10]. When the GHQ varia-
ble was removed from the model the strength of associa-
tions with other variables did not change, suggesting the
association between psychological disturbance and cough
is not acting directly through other factors.
The direction of causality regarding cough and psycholog-
ical problems is difficult to determine. We found that in
terms of disturbance on the GHQ-28 that the group with
cough a follow-up only was not significantly different
from those with cough at both time points, suggesting
there may be little effect of chronicity over our follow-up
period of 4 to 5 years. However, we do not know if people
had cough for all the follow-up period or recurrent cough
only in the 3 months prior to each clinic assessment.
Although those people with cough at baseline but who
were no longer coughing had significantly higher physical
health quality of life and were less likely to report distur-
bance on the GHQ. This can be interpreted as indicating
chronic cough has both immediate and longer-term con-
sequences for psychological health that may stem from
the significant impact on general health experienced with
cough. Alternatively, this may suggest chronic cough is
more likely to be seen in those with underlying anxiety or
depression, and this may influence an individual's aware-
ness of symptoms. However, anxiety about underlying
serious illness has been identified as a concern for most
patients with chronic cough [50]. McGarvey and col-
leagues found no difference in anxiety trait measures
between adults with persistent or idiopathic cough com-
pared with those whose cough was successfully treated
[20]. There is not a close association between adverse
effects of chronic cough and any specific causes, suggest-
ing the adverse effects are related to the chronic cough
itself [18]. Successful treatment of cough can improve
depression [19]. Furthermore, the GHQ is an instrument
designed to identify "the appearance of new phenomena
of a distressing nature [34], rather than lifelong traits. It
seems likely that there is a complex interplay between
cough and psychological traits and problems that may
vary with time.
Contrary to anecdotal observations, and consequent to
the representativeness of our sample we found cough to
be more common in men and in people aged over 60
years, two groups where there is evidence to suggest there
is a tendency to under-report symptoms to clinicians [51].
Older population surveys have reported that cough is
commoner in men [52,53], but women are more likely to
be seen in specialist cough clinics [4,5]. French et al
reported that women with chronic cough are more
inclined to present for medical attention than men
because of greater HRQL impairments and cough-related
psychosocial issues such as embarrassment caused by
cough induced stress incontinence [54]. Whether men are
less likely to report cough as a symptom to primary care
practitioners unless specifically asked remains an open
question [55]. However, as indicated earlier, given the
prevalence of cough and related physical and mental
health problems, there is a case to be made that simple
enquiry about coughing may be worthwhile as screening
tool for men in general practice, particularly in smokers,
the obese, those with a history of allergy or from socially
disadvantaged backgrounds. Previous population-based
studies have excluded older age groups. The consistent
association of chronic cough with advancing age in peo-
ple without other recognized lung disease seen in our
study again suggests that efforts at identifying and manag-
ing chronic cough and its related problems in older adults
may make a major contribution to reducing morbidity in
this burgeoning sector of the population.
Our study is limited by a lack of specific information
regarding some of the common causes of chronic cough,
such as upper airways syndrome or gastro-esophagealCough 2009, 5:10 http://www.coughjournal.com/content/5/1/10
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reflux disease [4,5]. However, cough was marginally
related to atopy, which itself is closely related to allergic
rhinitis, a major cause of post-nasal drip syndrome. Also,
it is now appreciated that the postnasal drip syndrome,
like GERD, may be clinically silent [56], suggesting that
self-report of symptoms may not accurately elicit these
problems sufficiently to be confident of any associations
in population studies. We were unable to identify people
with undiagnosed respiratory disease that did not produce
airways obstruction or restriction on spirometry, nor
those with undiagnosed cough-variant asthma with nor-
mal spirometry. However, many people with cough-vari-
ant asthma develop wheezing within 3 years [57], and
may have been diagnosed between baseline and follow-
up. In addition, the similarity in multivariable models
when identified asthma and COPD were included or
omitted from the analyses suggests the findings are
robust. Our survey was limited to households with tele-
phones, but as 97% of the households in the region have
telephones and the demographic characteristics were rep-
resentative of the population of profile of Adelaide overall
[37,38], the extent of any bias is likely to be small. There
was also a potential bias from survey non-response,
although response rates in our sample were higher than
comparable biomedical population studies [58]. The
strength of this study is the large representative popula-
tion sample measurements of other known respiratory
problems, and low drop-out rate in follow-up, especially
in people over 45 years who are more likely to be at risk
for chronic cough.
In summary, chronic cough is a common problem that is
significantly associated with reductions in physical and
mental health. Investigation and management of chronic
cough is therefore an important medical need. Patients
with a history of smoking, obesity, allergy, or use of ACE
inhibitors should be questioned regarding cough and
active clinical care pursued. Careful attention to symp-
toms of psychological disturbance, including somatic
symptoms, and their management may help identify
depression and reduce the burden of this problem. Con-
versely, specifically inquiring about cough in patients
with mental health problems may identify reversible
physical and psychological morbidity in this group.
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